BACK TO ALL REFERENCES
PREDICTFTD: Transforming the diagnosis and treatment of fronto-temporal dementia (FTD)
The PREDICTFTD project aims to transform the diagnosis and treatment of frontotemporal dementia (FTD). It seeks to accelerate the validation of predictive liquid biomarkers, which hold the potential to significantly enhance early detection and classification of this debilitating condition.
€7.9 m
in funding
4.5
years
15
partners
Key numbers
About the project
By combining data from 11 diverse cohorts, the PREDICTFTD project will implement a two-stage validation strategy to address critical challenges in distinguishing sporadic FTD from other disorders, detecting pathological subtypes and identifying the earliest changes in the presymptomatic phase of the disease. Ultimately, PREDICTFTD seeks to improve patient care, inform treatment decisions and support clinical trial recruitment.
Impact of the project:
Improved patient outcomes, quality of life and reduced costs by earlier and more accurate diagnosis, tailored support and symptomatic treatments.
Funding instrument Horizon Europe
Spinverse’s role
Spinverse health domain professionals provided their expertise in this complex funding proposal process and also supported the consortium building by adding relevant partners to the project.
This collaboration helped in ticking all the boxes for a successful funding proposal, which received a full 15/15 score from the evaluators.
The Spinverse team was crucial for the coordination of consortium teams and their ideas for the submission of the PREDICTFTD proposal. They were able to link all the parts effectively and get the best out of every partner.
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
